Prevention: Factors Hindering the Development of a Malaria Vaccine
vaccine against this disease. However, there’s light at the end of the tunnel…
Detailsvaccine against this disease. However, there’s light at the end of the tunnel…
DetailsThe ACB has engaged in technical discussions with country implementers and CCMs of six countries with high burden of TB, HIV/TB and MDR-TB in Africa burden countries to better understand their situation and potential solutions on how to reduce TB burden without affecting malaria and HIV programs negatively. Countries involved in these discussions that were held virtually on 26th August 2021 are [1]Kenya, Nigeria, Sierra Leone, Tanzania, Zimbabwe and South Africa. The input of these countries and other ongoing consultations will help determine a position that reflects the possible variety of situations across the 46 countries of both our ESA and WCA constituencies.
DetailsBy Djesika Amendah The Global Fund to fight HIV, TB and malaria invests 52% of its considerable resources, 14 billion of USD for three years, to fight HIV. HIV in sub-Saharan Africa is mostly young girls’ and women disease; thus, a high proportion of children are born with or infected in infancy in Africa. Outside…
DetailsBy Paul Nesara Many African countries are facing multi-faceted policy challenges, in part, due to the quality of data collected or the verticalized “big data” existing ecosystems that are not fully interrogated to generate evidence. Blumer et al., describe big data as “the extensive volume of information that individuals and agencies generate daily”.[1] There are…
DetailsOn 27th August 2021, the African Constituency Bureau attended the passing of the torch caravan from Ethiopia to Tanzania organized by Global Fund Advocacy Network (GFAN), ending a week of activities to celebrate the 20th anniversary of GF in Ethiopia. Over the 20-year period, since its inception, the Global Fund partnership has saved 38 million lives and this was the greatest opportunity to reflect on the past 20 years of unfailing support to African Countries such as Ethiopia.
DetailsThis interactive session held on 27 July 2021, saw subject experts, including participants from African Risk Capacity (ARC), WHO/AFRO, Ministry of Health of Kenya and ACB board members sharing their insights on priority areas to strengthen PPR in the continent. Key lessons learnt in the implementation of the COVID-19 Strategic Preparedness and Response in African Constituencies[2] as well as policy recommendations for the Global Fund were discussed.
DetailsBefore human behavior can be addressed, the mindset has to be understood. When it comes to consensual sex and HIV/AIDS transmission, the mind is where the first keg starts churning
DetailsKey points of the Post-2022 Strategy The Board meeting reaffirmed the importance of placing people and communities at the centre of the response to the three diseases as well as the importance of strong and sustainable systems in the fight against HIV, along with human rights, equity and gender issues.
DetailsApproximately 40 years after the onset of HIV/AIDS, the research community is still struggling to find a vaccine for the disease that continues to claim many lives around the world. There was even a feeling of despair when, in February 2020, the National Institute of Allergy and Infectious Disease (NIAID) in the United States announced…
DetailsOn 8th June, 2021 ACB conducted its second virtual coffee session which focused on malaria resurgence in Africa. The virtual coffee sessions are part of the ACBs Africa Voice for the Global Fund Campaign and therefore, this session drew people from diverse backgrounds working on malaria mitigation from different angles. Sixty-three participants come to participate…
Details